Axonyx Off Hook For Alzheimer's Drug Securities Suit
By Christopher Norton ( March 24, 2010, 3:29 PM EDT) -- A federal appeals court has extinguished a securities class action alleging pharmaceutical firm Axonyx Inc. misled investors about the promise of its experimental Alzheimer's disease treatment Phenserine....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.